Gene · 6362
Papers4,584
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,584
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of the LEP gene with immune infiltration as a diagnostic biomarker in preeclampsia. | Front Mol Biosci | 2023 | 37635936 | PubTator, text mining | PubMed |
| Coordinated single-cell tumor microenvironment dynamics reinforce pancreatic cancer subtype. | Nat Commun | 2023 | 37633924 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| Advancing Immunotherapies for HPV-Related Cancers: Exploring Novel Vaccine Strategies and the Influence of Tumor Microenvironment. | Vaccines (Basel) | 2023 | 37631922 | PubTator, text mining | PubMed |
| Molecularly Imprinted Polymers for Pharmaceutical Impurities: Design and Synthesis Methods. | Polymers (Basel) | 2023 | 37631457 | PubTator, text mining | PubMed |
| A Review: The Potential Involvement of Growth Arrest-Specific 6 and Its Receptors in the Pathogenesis of Lung Damage and in Coronavirus Disease 2019. | Microorganisms | 2023 | 37630598 | PubTator, text mining | PubMed |
| Macrophage Profiling in Head and Neck Cancer to Improve Patient Prognosis and Assessment of Cancer Cell-Macrophage Interactions Using Three-Dimensional Coculture Models. | Int J Mol Sci | 2023 | 37628994 | PubTator, text mining | PubMed |
| Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Reveals That TAM2-Driven Genes Affect Immunotherapeutic Response and Prognosis in Pancreatic Cancer. | Int J Mol Sci | 2023 | 37628967 | PubTator, text mining | PubMed |
| Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 37628831 | PubTator, text mining | PubMed |
| Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation. | Cells | 2023 | 37626849 | PubTator, text mining | PubMed |
| Precision medicine advances in idiopathic pulmonary fibrosis. | EBioMedicine | 2023 | 37625268 | PubTator, text mining | PubMed |
| Genetic and geographic influence on phenotypic variation in European sarcoidosis patients. | Front Med (Lausanne) | 2023 | 37621457 | PubTator, text mining | PubMed |
| Biomarkers related to silicosis and pulmonary function in individuals exposed to silica. | Am J Ind Med | 2023 | 37615855 | PubTator, text mining | PubMed |
| Advances in single-cell RNA sequencing and its applications in cancer research. | J Hematol Oncol | 2023 | 37612741 | PubTator, text mining | PubMed |
| Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. | Nat Commun | 2023 | 37612267 | PubTator, text mining | PubMed |
| iDESC: identifying differential expression in single-cell RNA sequencing data with multiple subjects. | BMC Bioinformatics | 2023 | 37608264 | PubTator, text mining | PubMed |
| Management goals of type 1 Gaucher disease in South Africa: An expert Delphi consensus document on good clinical practice. | PLoS One | 2023 | 37607165 | PubTator, text mining | PubMed |
| Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits. | Nat Commun | 2023 | 37604891 | PubTator, text mining | PubMed |
| Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapy. | Cell Genom | 2023 | 37601967 | PubTator, text mining | PubMed |
| Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition. | Front Pharmacol | 2023 | 37601070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6362/papers?page=26